Syndromic panel-based testing in clinical microbiology

Poornima Ramanan, Alexandra L. Bryson, Matthew J. Binnicker, Bobbi S. Pritt, Robin Patel

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.

Original languageEnglish (US)
Article numbere00024-17
JournalClinical Microbiology Reviews
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Central Nervous System Infections
Molecular Pathology
United States Food and Drug Administration
Microbiology
Respiratory System
Cerebrospinal Fluid
Delivery of Health Care
Costs and Cost Analysis
Blood Culture

Keywords

  • Molecular methods
  • Multiplex PCR
  • Syndromic testing

ASJC Scopus subject areas

  • Epidemiology
  • Immunology and Microbiology(all)
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018). Syndromic panel-based testing in clinical microbiology. Clinical Microbiology Reviews, 31(1), [e00024-17]. https://doi.org/10.1128/CMR.00024-17

Syndromic panel-based testing in clinical microbiology. / Ramanan, Poornima; Bryson, Alexandra L.; Binnicker, Matthew J.; Pritt, Bobbi S.; Patel, Robin.

In: Clinical Microbiology Reviews, Vol. 31, No. 1, e00024-17, 01.01.2018.

Research output: Contribution to journalReview article

Ramanan, P, Bryson, AL, Binnicker, MJ, Pritt, BS & Patel, R 2018, 'Syndromic panel-based testing in clinical microbiology', Clinical Microbiology Reviews, vol. 31, no. 1, e00024-17. https://doi.org/10.1128/CMR.00024-17
Ramanan, Poornima ; Bryson, Alexandra L. ; Binnicker, Matthew J. ; Pritt, Bobbi S. ; Patel, Robin. / Syndromic panel-based testing in clinical microbiology. In: Clinical Microbiology Reviews. 2018 ; Vol. 31, No. 1.
@article{80798951e1d440f48a2ffe568907a6f0,
title = "Syndromic panel-based testing in clinical microbiology",
abstract = "The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.",
keywords = "Molecular methods, Multiplex PCR, Syndromic testing",
author = "Poornima Ramanan and Bryson, {Alexandra L.} and Binnicker, {Matthew J.} and Pritt, {Bobbi S.} and Robin Patel",
year = "2018",
month = "1",
day = "1",
doi = "10.1128/CMR.00024-17",
language = "English (US)",
volume = "31",
journal = "Clinical Microbiology Reviews",
issn = "0893-8512",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Syndromic panel-based testing in clinical microbiology

AU - Ramanan, Poornima

AU - Bryson, Alexandra L.

AU - Binnicker, Matthew J.

AU - Pritt, Bobbi S.

AU - Patel, Robin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.

AB - The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.

KW - Molecular methods

KW - Multiplex PCR

KW - Syndromic testing

UR - http://www.scopus.com/inward/record.url?scp=85034596824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034596824&partnerID=8YFLogxK

U2 - 10.1128/CMR.00024-17

DO - 10.1128/CMR.00024-17

M3 - Review article

VL - 31

JO - Clinical Microbiology Reviews

JF - Clinical Microbiology Reviews

SN - 0893-8512

IS - 1

M1 - e00024-17

ER -